Gossamer Threads Inc.: Search   
   Search     Add a Site      Modify a Site     What's New     What's Cool     Top Rated     Random Link     Login
Find this:     the entire directory only this category
banner goes here
Home: Science: LINKS_PAGE
     
  • Cantech Networks Announces Official Partnership with cPanel - Cantech Networks, a leading web hosting solutions provider, is thrilled to announce its official partnership with cPanel, a renowned web hosting management tool. This strategic alliance marks a significant milestone in the tech industry, promising innovative solutions and enhanced services for clients worldwide. Cantech Networks, known for its commitment to excellence and cutting-edge technology solutions, has established itself as a trusted name in the IT industry. This partnership with cPanel, a globally recognized leader in web hosting management, solidifies Cantech Networks's dedication to delivering the best-in-class services to its clients. "We are excited to partner with cPanel, a company that shares our vision of providing top-notch solutions to businesses and individuals," said Devarsh Pandya, CEO of Cantech Networks. "This collaboration will enable us to leverage cPanel's robust platform to streamline web hosting management and offer our clients an even more seamless experience." Benefits of the Cantech Networks-cPanel Partnership: Enhanced Hosting Solutions: Clients of Cantech Networks can expect a broader range of hosting solutions with improved functionality and performance. This is particularly advantageous for those who choose VPS and Dedicated Server services, as they can access exclusive support services through cPanel and significantly boost the capabilities of their servers. Streamlined Management: The integration of cPanel's user-friendly interface will simplify website and server management, making it easier for clients to navigate and control their hosting environments. Dedicated Support: Cantech Networks's experienced team will provide dedicated support and expertise to ensure clients make the most of cPanel's features. Innovation and Growth: The partnership between Cantech Networks and cPanel promises ongoing innovation and growth, as both companies work together to develop new solutions and services. The official partnership between Cantech Networks and cPanel is effective immediately. Clients and businesses interested in benefiting from this collaboration can reach out to Cantech Networks for more information on the services and solutions available. About Cantech Networks: Cantech Networks is a leading web hosting provider, specializing in dedicated servers, cloud services, and other hosting services. With a commitment to innovation and excellence, Cantech Networks helps businesses and organizations harness the power of technology to achieve their goals. (Added: Wed Sep 20 2023 Hits: 49 Rating: 0.00 Votes: 0) Rate It
  • Accreditationconsultancy.Com. has Launched Online ISO/IEC 17065 Auditor Training Courses - Accreditationconsultancy.com is pleased to announce the launch of an ISO/IEC 17065 accredited auditor training courses online. These online courses - ISO/IEC 17065 auditor training and ISO/IEC 17065 Assessor Training are specifically developed for students who wish to study auditing methodologies based on ISO/IEC 17065 as well as understand the ISO/IEC 17065 Conformity Assessment — Requirements for bodies certifying products, processes, and services in depth. The ISO 17065 auditor training online course enables certifying body staff to qualify as an 'Internal Auditor' for a quality management system that follows ISO/IEC 17065. The Online ISO/IEC 17065 Auditor training – online courses will be valuable for anyone who wants to become a lead auditor or has previously participated in ISO 17065 audits of such certification bodies. This course offers a full overview of all the features and requirements of ISO/IEC 17065, the need for documentation in compliance with ISO/IEC 17065, stages for ISO 17065 accreditation, audit processes and techniques, and so on. The ISO 17065 auditor training and ISO/IEC 17065 assessor training, both the E-learning courses consist of interactive online sessions that comprise lectures, audio-visual presentations, handouts, and online exams to guarantee a thorough comprehension of the subject. These courses provide an overview of the ISO/IEC 17065 management system, its requirements, resource and process requirements. It also covers documentation, procedures, records, internal auditing, audit checklists, and concepts like impartiality and risk to impartiality. The main goal of such online courses is to learn online at user’s own time and understand how to prepare and maintain internal audit records, use an audit checklist, how to audit implemented system and establish an effective system for ISO/IEC 17065 accreditation. These online ISO/IEC 17065 auditor courses are developed for working professionals, college students, and other persons looking to advance their careers. The e-learning courses assist clients in succeeding in today's competitive climate, renewing licences, and updating, strengthening, and improving the quality of their existing knowledge and abilities. These courses are also beneficial to people who want to obtain or renew certification/accreditation for their organization or begin a new career. This course was developed by a team of expert ISO 17065 consultants and auditors with over 25 years of experience in ISO and management consulting in over 35 countries across the world, as well as building and delivering numerous e-learning courses and training programs in convenient and cost-effective ways. Regarding www.Accreditationconsultancy.com Accreditationconsultancy.com is an online provider of ISO/IEC accreditation solutions operated by the Global Manager Group. The company provides benefits to laboratories or organizations by providing information on all ISO Accreditation Standards. The organization has a team of experienced consultants with extensive experience in implementing various international system certifications and/or documentation that collaborate with their customers to cut costs and save time while installing the system. The website provides certification solutions for ISO 17020, ISO 17021, ISO 17024, ISO 17025, ISO 17034, ISO 17043, ISO 15189, ISO 17065, and more. (Added: Tue Sep 19 2023 Hits: 67 Rating: 0.00 Votes: 0) Rate It
  • 12th International Conference On Recent Challenges In Engineering And Technology(ICRCET) - One of the primary motives of the 11th International Conference On Recent Challenges In Engineering and Technology (ICRCET-24) to be held in Jakarta, Indonesia on the 16th - 17th June 2024 is a fantastic opportunity for Engineers, Research Scholar and Students to network with other experts and people in the relevant field of technology. There will be new equipment, technologies, or procedures introduced & demonstrated, and discussions about engineering obstacles and how to handle them. (Added: Thu Sep 14 2023 Hits: 92 Rating: 0.00 Votes: 0) Rate It
  • 12th International Conference On Recent Challenges In Engineering And Technology(ICRCET) - One of the primary motives of the 11th International Conference On Recent Challenges In Engineering and Technology (ICRCET-24) to be held in Jakarta, Indonesia on the 16th - 17th June 2024 is a fantastic opportunity for Engineers, Research Scholar and Students to network with other experts and people in the relevant field of technology. There will be new equipment, technologies, or procedures introduced & demonstrated, and discussions about engineering obstacles and how to handle them. (Added: Thu Sep 14 2023 Hits: 85 Rating: 0.00 Votes: 0) Rate It
  • Creative Biolabs Updated 2023 Scholarship Program to Support Future Scientists in Life Sciences - Creative Biolabs has established itself as a prominent player in the biotechnology industry, making significant contributions to various areas of life sciences, like antibodies, ADC development, and immunotherapies. The company has built a reputation as a trusted partner for academic researchers, pharmaceutical companies, and biotech startups, offering high-quality services and customized solutions. Creative Biolabs Scholarship Program The Creative Biolabs scholarship program is set to support undergraduate and graduate students studying life sciences who demonstrate academic excellence and a strong passion for advancing the field. By inspiring students to contribute to cutting-edge research projects, the program seeks to foster scientific progress. Eligibility Criteria The eligibility criteria are fair and reasonable, ensuring that deserving students receive the scholarship award. The minimum GPA requirement of 3.0 ensures that only students with above-average academic performance are considered. Additionally, extracurricular activities, leadership skills, and community involvement are taken into consideration, ensuring a comprehensive selection process. Scholarship Details Selected applicants will be awarded a scholarship of $1,000, which can be utilized for tuition fees or educational expenses related to their studies in the sciences. Creative Biolabs will review all applications and select the most deserving candidate to receive the scholarship. Application Process To apply for the Creative Biolabs Scholarship Program, students must complete an application form and submit it along with their academic transcripts, a reference letter from a teacher, school counselor, or community leader, and either a written essay of 800–1,000 words or a PowerPoint presentation of 10–12 pages with detailed lecture notes. The essay or PowerPoint submission should be original, grammatically correct, and emphasize the applicant's passion for their field of study, achievements, and future plans. The essay or PowerPoint requirement also allows the selection committee to evaluate the student's writing and presentation skills, which are essential qualities in their chosen field. All applications and supporting documents should be sent online to the designated email address. All applications must be submitted by September 30, 2023, and winners will be announced in October 2023. More details about the scholarship program can be found at https://www.creative-biolabs.com/. About Creative Biolabs is a cutting-edge biotech company that has emerged as a global leader in the field of antibody discovery and development. With a strong commitment to innovation and scientific excellence, Creative Biolabs has revolutionized the way antibodies are engineered and utilized in various research and therapeutic applications. At the core of Creative Biolabs' expertise lies their extensive premade antibody libraries, which serve as invaluable resources, providing researchers with an extensive repertoire of antibody candidates for targeted applications such as drug discovery, diagnostics, and immunotherapy. (Added: Thu Sep 14 2023 Hits: 79 Rating: 0.00 Votes: 0) Rate It
  • Creative Biolabs Updated 2023 Scholarship Program to Support Future Scientists in Life Sciences - Creative Biolabs has established itself as a prominent player in the biotechnology industry, making significant contributions to various areas of life sciences, like antibodies, ADC development, and immunotherapies. The company has built a reputation as a trusted partner for academic researchers, pharmaceutical companies, and biotech startups, offering high-quality services and customized solutions. Creative Biolabs Scholarship Program The Creative Biolabs scholarship program is set to support undergraduate and graduate students studying life sciences who demonstrate academic excellence and a strong passion for advancing the field. By inspiring students to contribute to cutting-edge research projects, the program seeks to foster scientific progress. Eligibility Criteria The eligibility criteria are fair and reasonable, ensuring that deserving students receive the scholarship award. The minimum GPA requirement of 3.0 ensures that only students with above-average academic performance are considered. Additionally, extracurricular activities, leadership skills, and community involvement are taken into consideration, ensuring a comprehensive selection process. Scholarship Details Selected applicants will be awarded a scholarship of $1,000, which can be utilized for tuition fees or educational expenses related to their studies in the sciences. Creative Biolabs will review all applications and select the most deserving candidate to receive the scholarship. Application Process To apply for the Creative Biolabs Scholarship Program, students must complete an application form and submit it along with their academic transcripts, a reference letter from a teacher, school counselor, or community leader, and either a written essay of 800–1,000 words or a PowerPoint presentation of 10–12 pages with detailed lecture notes. The essay or PowerPoint submission should be original, grammatically correct, and emphasize the applicant's passion for their field of study, achievements, and future plans. The essay or PowerPoint requirement also allows the selection committee to evaluate the student's writing and presentation skills, which are essential qualities in their chosen field. All applications and supporting documents should be sent online to the designated email address. All applications must be submitted by September 30, 2023, and winners will be announced in October 2023. More details about the scholarship program can be found at https://www.creative-biolabs.com/. About Creative Biolabs is a cutting-edge biotech company that has emerged as a global leader in the field of antibody discovery and development. With a strong commitment to innovation and scientific excellence, Creative Biolabs has revolutionized the way antibodies are engineered and utilized in various research and therapeutic applications. At the core of Creative Biolabs' expertise lies their extensive premade antibody libraries, which serve as invaluable resources, providing researchers with an extensive repertoire of antibody candidates for targeted applications such as drug discovery, diagnostics, and immunotherapy. (Added: Thu Sep 14 2023 Hits: 92 Rating: 0.00 Votes: 0) Rate It
  • Intercity Transport Agency in Delhi - Introducing "Intercity Transport Agency in Delhi," your trusted partner for seamless intercity logistics solutions. We are dedicated to redefining the transport experience in the heart of India's capital. With a commitment to reliability and efficiency, we specialize in connecting businesses and individuals with a network of modern, well-maintained vehicles and highly skilled drivers. Our services encompass swift point-to-point deliveries, safe cargo transportation, and comfortable passenger journeys. Whether you require goods transported across Delhi or need a stress-free ride to another city, our agency stands as a beacon of quality and punctuality. Choose us for your intercity transport needs and experience a journey beyond expectations. (Added: Wed Sep 13 2023 Hits: 84 Rating: 0.00 Votes: 0) Rate It
  • Biomedical Engineering and Biotechnology - Xperts Meetings invites all the participants across the globe to attend “International Conference on Biomedical Engineering and Biotechnology (BioMed-2024 – Hybrid Edition)” during on August 19-21, 2024, in Lisbon, Portugal and Virtually by Zoom. BioMed-2024 will include several plenary talks, keynote lectures, interactive sessions, academic discussions, oral and poster presentations, technical workshops and social events that will provide huge networking opportunities for the participants to share their experiences and new innovations on all aspects of Biomedical Engineering and Biotechnology. The organizing committee will include leaders in the field of Biomedical Engineering and Biotechnology and will guide the participants on the latest developments and emerging challenges in these fields. (Added: Sun Sep 10 2023 Hits: 133 Rating: 0.00 Votes: 0) Rate It
  • Biomedical Engineering and Biotechnology - Xperts Meetings invites all the participants across the globe to attend “International Conference on Biomedical Engineering and Biotechnology (BioMed-2024 – Hybrid Edition)” during on August 19-21, 2024, in Lisbon, Portugal and Virtually by Zoom. BioMed-2024 will include several plenary talks, keynote lectures, interactive sessions, academic discussions, oral and poster presentations, technical workshops and social events that will provide huge networking opportunities for the participants to share their experiences and new innovations on all aspects of Biomedical Engineering and Biotechnology. The organizing committee will include leaders in the field of Biomedical Engineering and Biotechnology and will guide the participants on the latest developments and emerging challenges in these fields. (Added: Sun Sep 10 2023 Hits: 156 Rating: 0.00 Votes: 0) Rate It
  • 6th World Summit on Women’s Health and Cancer Awareness - The 6th World Summit on Women's Health and Cancer Awareness is a highly anticipated international conference scheduled to take place on February 23-24 in the beautiful city of Barcelona, Spain. This prominent event aims to bring together leading experts, researchers, healthcare professionals, advocates, and policy-makers from around the world to discuss and address critical issues in women's health and cancer awareness. The conference will serve as a platform for sharing groundbreaking research findings, innovative treatment approaches, and best practices in the field of women's health and cancer prevention. It will feature a diverse range of sessions, keynote presentations, panel discussions, and interactive workshops, covering a wide spectrum of topics related to women's health, including breast health, reproductive health, gynecological cancers, mental health, and more. Attendees will have the opportunity to engage in thought-provoking discussions, network with peers, and gain insights from esteemed speakers who are at the forefront of women's health and cancer research. The conference will foster collaboration and knowledge exchange, facilitating the development of strategies and initiatives to improve women's health outcomes and enhance cancer awareness globally. (Added: Sat Aug 05 2023 Hits: 68 Rating: 0.00 Votes: 0) Rate It
  • The 13th Annual World Congress of Neurotalk-2023 - Neurotalk 2023 is a science and technology event which brings together neuroscientists, neurologists and neurosurgeons from around the globe gather to exchange ideas and debut cutting-edge research and therapy-oriented technologies in the key areas of clinical neurology, provides participating scientists and clinicians with a unique networking platform. Neurotalk 2023 enables presenters and delegates to enjoy the state of the art oral and poster presentations covering the in-depth findings and the extraordinary advances on the treatment of injuries and illnesses affecting the brain, spine and nervous system. (Added: Wed Jul 26 2023 Hits: 68 Rating: 0.00 Votes: 0) Rate It
  • 7th International Conference on Translational Medicine and Bioengineering - Translational Medicine unequivocally respects all of the individuals over the globe from driving colleges, research foundations, expressive associations and all interested to allocate their assessment experiences in 7th International Conference on Translational Medicine and Bioengineering on October 10-11, 2023 in Madrid, Spain. In today’s economic climate your business decisions are as crucial as ever. 7th International Conference on Translational Medicine and Bioengineering allows you to maximize your time and marketing dollars while receiving immediate feedback on your new products and services. Translational medicine, also called translational life science, preclinical research, evidence-based research, or disease-targeted research, area of research that aims to enhance human health and longevity by determining the relevance to human disease of novel discoveries within the biological sciences. Translational medicine seeks to coordinate the utilization of the latest knowledge in clinical practice and to include clinical observations and questions into scientific hypotheses within the laboratory. (Added: Fri Jul 21 2023 Hits: 53 Rating: 0.00 Votes: 0) Rate It
  • 7th International Conference on Translational Medicine and Bioengineering - Translational Medicine unequivocally respects all of the individuals over the globe from driving colleges, research foundations, expressive associations and all interested to allocate their assessment experiences in 7th International Conference on Translational Medicine and Bioengineering on October 10-11, 2023 in Madrid, Spain. In today’s economic climate your business decisions are as crucial as ever. 7th International Conference on Translational Medicine and Bioengineering allows you to maximize your time and marketing dollars while receiving immediate feedback on your new products and services. Translational medicine, also called translational life science, preclinical research, evidence-based research, or disease-targeted research, area of research that aims to enhance human health and longevity by determining the relevance to human disease of novel discoveries within the biological sciences. Translational medicine seeks to coordinate the utilization of the latest knowledge in clinical practice and to include clinical observations and questions into scientific hypotheses within the laboratory. (Added: Fri Jul 21 2023 Hits: 59 Rating: 0.00 Votes: 0) Rate It
  • World Congress on Pharmaceutics & Novel Drug Delivery Systems - We are glad to welcome participants from around the globe to our upcoming “World Congress on Pharmaceutics & Novel Drug Delivery Systems” during November 22-23, 2023 in Dubai, UAE. We are Specialized in executing successful conferences across the globe for the dissemination of knowledge among eminent scientists, researchers, institutions, and associations (Added: Wed Jul 19 2023 Hits: 90 Rating: 0.00 Votes: 0) Rate It
  • The Immune Checkpoint Holds Great Promise for Cancer Immunotherapy - Cancer is a severe public health issue and one of the main causes of morbidity and mortality worldwide. However, the effect of chemoradiotherapy for cancer or tumor may be limited due to serious side effects and drug resistance. Therefore, it is essential to develop novel therapies for cancer treatment. In 2018, James P. Allison and Tasuku Honjo's research on the immune checkpoints programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) demonstrated that they acted as a "brake" in immune function and suggested that immune checkpoint inhibition may reactivate T cells and eliminate cancer cells more effectively. Preclinical studies showing decreased tumor growth and improved survival with CTLA-4 or PD-1 pathway blockade provide the rationale for immune checkpoint inhibition for cancer treatment.  Truly, the discovery of the checkpoint molecules CTLA-4 and PD-1 has pushed the pharmaceutical industry to develop specific inhibitors for cancer treatments, driving many scientists and physicians to further explore this area in recent years. Especially notable is the significant accomplishment in the treatment of malignant melanoma, where no advance has been made in the therapy of this terrible illness in more than 30 years. Besides, monoclonal antibodies that block CTLA-4 or PD-1 are in development for other tumor types, including kidney cancer, prostate cancer, and head and neck cancer. Other agents specifically targeting PD-L1 are also in development. While CTLA-4 and PD-1 blockade has proved successful in improving survival rates, many patients do not respond or develop resistance to these interventions. Pre-clinical and clinical studies, on the other hand, have shown that combining two distinct immunological checkpoints as therapeutic targets, such as CTLA-4 and PD-1, LAG-3 and PD-1, TIM-3 and PD-1, and A2AR/PD-L1, has great potential. However, the path is still rocky. Many issues and questions arose during the experience with immunotherapeutic drugs targeting immunological checkpoint molecules. For instance, it is still not clear how to monitor the success of therapy, and many patients do not respond or develop resistance to interventions of PD-1 and CTLA-4. There is no doubt that these questions require further research. Therefore, studies focused on immune checkpoint molecules are under intensive investigation. Creative Biolabs is committed to providing immunotherapeutic development services, such as immune checkpoint-based antibodies, molecules, biomarkers, peptides, and proteins, to support research on cancer immunotherapy. In conclusion, immune checkpoint inhibition is a promising approach for treating cancer, with a considerable proportion of patients benefiting, despite its limitations in clinical use. Further studies on immune checkpoints are needed to address the existing problems and help more patients with tumors and other diseases. (Added: Wed Jul 05 2023 Hits: 80 Rating: 0.00 Votes: 0) Rate It
  • The Immune Checkpoint Holds Great Promise for Cancer Immunotherapy - Cancer is a severe public health issue and one of the main causes of morbidity and mortality worldwide. However, the effect of chemoradiotherapy for cancer or tumor may be limited due to serious side effects and drug resistance. Therefore, it is essential to develop novel therapies for cancer treatment. In 2018, James P. Allison and Tasuku Honjo's research on the immune checkpoints programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) demonstrated that they acted as a "brake" in immune function and suggested that immune checkpoint inhibition may reactivate T cells and eliminate cancer cells more effectively. Preclinical studies showing decreased tumor growth and improved survival with CTLA-4 or PD-1 pathway blockade provide the rationale for immune checkpoint inhibition for cancer treatment.  Truly, the discovery of the checkpoint molecules CTLA-4 and PD-1 has pushed the pharmaceutical industry to develop specific inhibitors for cancer treatments, driving many scientists and physicians to further explore this area in recent years. Especially notable is the significant accomplishment in the treatment of malignant melanoma, where no advance has been made in the therapy of this terrible illness in more than 30 years. Besides, monoclonal antibodies that block CTLA-4 or PD-1 are in development for other tumor types, including kidney cancer, prostate cancer, and head and neck cancer. Other agents specifically targeting PD-L1 are also in development. While CTLA-4 and PD-1 blockade has proved successful in improving survival rates, many patients do not respond or develop resistance to these interventions. Pre-clinical and clinical studies, on the other hand, have shown that combining two distinct immunological checkpoints as therapeutic targets, such as CTLA-4 and PD-1, LAG-3 and PD-1, TIM-3 and PD-1, and A2AR/PD-L1, has great potential. However, the path is still rocky. Many issues and questions arose during the experience with immunotherapeutic drugs targeting immunological checkpoint molecules. For instance, it is still not clear how to monitor the success of therapy, and many patients do not respond or develop resistance to interventions of PD-1 and CTLA-4. There is no doubt that these questions require further research. Therefore, studies focused on immune checkpoint molecules are under intensive investigation. Creative Biolabs is committed to providing immunotherapeutic development services, such as immune checkpoint-based antibodies, molecules, biomarkers, peptides, and proteins, to support research on cancer immunotherapy. In conclusion, immune checkpoint inhibition is a promising approach for treating cancer, with a considerable proportion of patients benefiting, despite its limitations in clinical use. Further studies on immune checkpoints are needed to address the existing problems and help more patients with tumors and other diseases. (Added: Wed Jul 05 2023 Hits: 84 Rating: 0.00 Votes: 0) Rate It
  • Ñòðåé÷ ïëåíêà - Ñòðåé÷ ïëåíêà ïî ëó÷øåé öåíå ñêåò÷ ïëåíêà https://streych-plenka01.ru/. (Added: Mon Jun 19 2023 Hits: 64 Rating: 0.00 Votes: 0) Rate It
  • Materials Science & Engineering - Tired of getting your research news from false social media posts? Tired of University restrictions on where and when you can travel? Tired of chasing after research that can get you research dollars for academic promotion, rather than what you are really interested in? Tired of unsuccessful researchers and administrators telling you want to research? Tired of reading countless literature articles to find that novel research? Tired of traditional conferences with the same old presentations by the same old people? Tired of not building new collaborations? You need a refresher and you need to reset ! Take back the science ! We are the researchers and the science is ours. Try new conferences. Try meeting new people. Try new research ideas. Here’s an idea that works for me… learn the latest science from new people at new conferences ! (Added: Sat Jun 17 2023 Hits: 60 Rating: 0.00 Votes: 0) Rate It
  • Biomedical Engineering and Biotechnology - Xperts Meetings invites all the participants across the globe to attend “International Conference on Biomedical Engineering and Biotechnology (BioMed-2024 – Hybrid Edition)” during on August 19-21, 2024, in Lisbon, Portugal and Virtually by Zoom. BioMed-2024 will include several plenary talks, keynote lectures, interactive sessions, academic discussions, oral and poster presentations, technical workshops and social events that will provide huge networking opportunities for the participants to share their experiences and new innovations on all aspects of Biomedical Engineering and Biotechnology. The organizing committee will include leaders in the field of Biomedical Engineering and Biotechnology and will guide the participants on the latest developments and emerging challenges in these fields (Added: Sat Jun 17 2023 Hits: 131 Rating: 0.00 Votes: 0) Rate It
  • Biomedical Engineering and Biotechnology - Xperts Meetings invites all the participants across the globe to attend “International Conference on Biomedical Engineering and Biotechnology (BioMed-2024 – Hybrid Edition)” during on August 19-21, 2024, in Lisbon, Portugal and Virtually by Zoom. BioMed-2024 will include several plenary talks, keynote lectures, interactive sessions, academic discussions, oral and poster presentations, technical workshops and social events that will provide huge networking opportunities for the participants to share their experiences and new innovations on all aspects of Biomedical Engineering and Biotechnology. The organizing committee will include leaders in the field of Biomedical Engineering and Biotechnology and will guide the participants on the latest developments and emerging challenges in these fields (Added: Sat Jun 17 2023 Hits: 128 Rating: 0.00 Votes: 0) Rate It
  • Biomedical Engineering and Biotechnology - Xperts Meetings invites all the participants across the globe to attend “International Conference on Biomedical Engineering and Biotechnology (BioMed-2024 – Hybrid Edition)” during on August 19-21, 2024, in Lisbon, Portugal and Virtually by Zoom. BioMed-2024 will include several plenary talks, keynote lectures, interactive sessions, academic discussions, oral and poster presentations, technical workshops and social events that will provide huge networking opportunities for the participants to share their experiences and new innovations on all aspects of Biomedical Engineering and Biotechnology. The organizing committee will include leaders in the field of Biomedical Engineering and Biotechnology and will guide the participants on the latest developments and emerging challenges in these fields (Added: Sat Jun 17 2023 Hits: 112 Rating: 0.00 Votes: 0) Rate It
  • Global Patent Analytics Market. - Global Patent Analytics Market refers to the market for services and tools that provide in-depth analysis and insights into patent-related data on a global scale Patent analytics involves the use of advanced techniques and tools to extract valuable. (Added: Tue Jun 06 2023 Hits: 86 Rating: 0.00 Votes: 0) Rate It
  • MEA RFID Market. - MEA RFID market faces several challenges that can hinder its growth and adoption. Firstly, one of the major challenges is the lack of awareness and understanding about RFID technology among businesses in the region. (Added: Tue Jun 06 2023 Hits: 80 Rating: 0.00 Votes: 0) Rate It
  • Australia Virtual School Market. - Australia Virtual School Market is a rapidly growing sector in the country's education industry. Virtual schools provide online learning platforms and resources for students, offering flexibility and personalized education experiences. (Added: Mon Jun 05 2023 Hits: 81 Rating: 0.00 Votes: 0) Rate It
  • Global Gasket Market. - global gasket market is segmented into various types, including spiral wound gaskets, ring joint gaskets, kammprofile gaskets, corrugated gaskets, jacketed gaskets, sheet gaskets, and others. (Added: Mon Jun 05 2023 Hits: 91 Rating: 0.00 Votes: 0) Rate It
  • Asia Pacific Construction Sand Market - Asia Pacific construction sand market was valued at USD 41.48 billion in 2020. The market is expected to grow at a CAGR of 6.41% during the forecast period (2023-2031), reaching a value of USD 85.17 billion by 2031. (Added: Thu May 18 2023 Hits: 106 Rating: 0.00 Votes: 0) Rate It
  • Vietnam Office Furniture Products Market - Vietnam office furniture market is expected to grow at a moderate growth rate, owing to rapidly expanding business environment and office culture. (Added: Wed May 17 2023 Hits: 73 Rating: 0.00 Votes: 0) Rate It
  • Nuclear Medicine Therapeutics Market: Developments and Outlook 2030 - Nuclear Medicine Therapeutics Market: Developments and Outlook Nuclear medicine has been increasingly prevalent in healthcare throughout time, notably in the realm of cancer therapy. Nuclear medicine therapy uses radioactive substances, or radioisotopes, to treat a variety of illnesses include cancer, thyroid problems, and bone pain. In the upcoming years, the market for nuclear medicine treatments is anticipated to expand as a result of developments in imaging technology and the creation of novel radioisotopes with therapeutic applications. The global market for nuclear medical therapies is anticipated to expand between 2023 and 2030 at a compound annual growth rate (CAGR) of around 8%, according to a research by Pharamanucleus. The research identifies a number of reasons, including rising prevalence, as the cause of this development. Iodine-131, which is used to treat thyroid cancer and hyperthyroidism, is one of the radioisotopes that is most frequently utilised in nuclear medicine therapy. The treatment of bone metastases, neuroendocrine tumours, and prostate cancer also uses other radioisotopes as radium-223, lutetium-177, and yttrium-90. To offer focused treatment and enhance patient outcomes, these radioisotopes are frequently employed in conjunction with imaging methods like positron emission tomography (PET) and single photon emission computed tomography (SPECT). It takes specific knowledge and equipment to utilise radioactive elements for medical reasons, and the market for nuclear medicine therapies is heavily controlled. The market is anticipated to expand despite these difficulties because of the rising incidence of cancer and the demand for more efficient treatment alternatives. In recent years, there have been significant advancements in nuclear medicine imaging technology, which has led to improved diagnosis and treatment of cancer. For example, theranostics is a new field of nuclear medicine that combines therapy and diagnostics. It involves the use of radioisotopes to both diagnose and treat cancer, allowing for more personalized and targeted treatment options. The market for nuclear medicine therapeutics is also seeing increased investment in research and development from key players in the industry. Companies such as Novartis International AG, Bayer AG, Cardinal Health, Inc., GE Healthcare, and Curium are investing heavily in developing new radioisotopes and improving imaging technology to provide better diagnosis and treatment options for patients. In conclusion, the nuclear medicine therapeutics market is expected to continue to grow in the coming years, driven by advancements in imaging technology and the development of new radioisotopes for therapeutic use. With increasing investment in research and development, the field of nuclear medicine is poised to make significant strides in the diagnosis and treatment of cancer, offering hope for improved outcomes and quality of life for patients. Download free sample: https://www.pharmanucleus.com/nuclear-medicine-therapeutics-market Contact Us: John.M john.m@pharmanucleus.com Support: +44 (0)20 8470 4967 https://www.pharmanucleus.com/ (Added: Tue May 09 2023 Hits: 196 Rating: 0.00 Votes: 0) Rate It
  • Aculon Measurement Integrity System Now Being Offered Through Angus Measurement Services, LLP - SAN DIEGO, Calif. (May, 2023)- Aculon® is pleased to announce the launch of the Aculon® Measurement Integrity (AMI) treatment into the Oil & Gas space through a strategic partnership with Angus Measurement Services, LP. The AMI treatment improves meter reliability and eliminates the need for routine maintenance caused by fouling or buildup on new and existing flow measurement devices. This is accomplished through a surface modification treatment that is proven to prevent these build ups inside the measuring devices. Fouling of flow measurement devices, particularly when used for custody transfer, is problematic as it yields metering uncertainty, costly routine maintenance, and downtime. AMI services are offered as an on-site treatment for existing and new equipment or can be performed at an AMI Service Center located, in either Odessa or Beeville Texas. “We are pleased to offer the best in class proven measurement integrity technology that has saved operators untold dollars in measurement errors and maintenance costs. Partnering with Angus Measurement Services, a leading measurement and proving company, will accelerate the adoption of this measurement integrity solution setting the gold standard for measurement,” said Edward Hughes CEO of Aculon inc. “At Angus our mission is to provide customers with highly valued measurement solutions. By combining industry leading measurement technologies with the AMI system, we can improve our customer’s experience, advance our solutions leadership, and drive product adoption that will improve customer’s operations and their bottom line,” said Steve Resnick, Vice President of Sales and Marketing, Angus Measurement Services, LP. The AMI treatment involves the application of Aculon’s AcuFlow® proprietary flow assurance nanoscale omniphobic treatment using KopMan’s Surface Property Modification Generation 3 Procedure to prevent fouling on flow measurement devices. Aculon’s AcuFlow® covalently bonds to metal alloys, rapidly reducing the surface energy of the treated product, which allows the surface to repel both oil and aqueous solutions. Covalently bonding to the surface reduces rework and results in long-term benefits such as increased instrumentation reliability, increased service life between cleaning, and reduced equipment downtime. The AMI treatment is a cost-effective solution that has been proven on over 6000 meters. About Aculon® Aculon® specializes in developing and producing unique surface modification technologies for electronics, consumer products, industrial and oil and gas industries. Aculon® has over 40 U.S. patents, has won many industry awards for innovation, and has worked on thousands of applications and invested hundreds of thousands of hours into solving customer surface-related issues. The company’s technologies include hydrophobic, superhydrophobic, oleophobic, and hydrophilic treatments to repel water, oil, paraffin and asphaltenes as well as almost all liquids. These treatments are thin, often nano-scale, and are easy to apply. Aculon is based in San Diego, California and operates globally with operations in Europe and Asia. Aculon® is ISO 9001. Learn more at aculon.com. About Kopman Kopman was developed in 2019 after a 5-year case study with a major operator focused on building process and procedures to clean, prep, and treat (CPT) surface areas regarding Oil & Gas production equipment. With over 6000 units CPT and tested and not 1 return over that 5-year Research and Development period, KopMan entered the market to provide the AMI treatment to the O&G upstream industry from the service perspective. About Angus Measurement Services LP Angus Measurement began in Odessa, Texas in 1998 as a measurement company. Today, Angus Measurement is the leader in the manufacturing and control of high-quality, custom-engineered, liquid custody and allocation measurement systems. In addition to measurement systems, Angus Measurement provides industry leading flow measuring and control technologies and a variety of specialized services to the upstream and midstream oil and gas market. With a team of experienced oil and gas professionals, Angus Measurement works with customers to deliver differentiated measurement solutions, products, and services. Learn more at https://angusmeasurement.com/. (Added: Thu May 04 2023 Hits: 61 Rating: 0.00 Votes: 0) Rate It
  • Meadowlark Optics Acquires Boulder Nonlinear Systems - Meadowlark Optics (Meadowlark) announces its acquisition of Boulder Nonlinear Systems (BNS.) Both companies are based in Colorado and produce cutting-edge optical components used in multiple branches of scientific research and industry. Meadowlark previously purchased the commercial Spatial Light Modulator business from BNS in 2014. The latest acquisition combines products, research, and expertise under one roof. “Both Meadowlark and BNS have storied histories of advancing polarization science. Combining the resources of both companies will further strengthen our standing in the marketplace,” commented Garry Gorsuch, Meadowlark Optics’ President and CEO. The acquisition of BNS supports Meadowlark’s mission to offer unmatched quality in catalog and custom polarization components. The company will be gaining additional products to expand upon the spatial light modulators and liquid crystal polarization products, which will now include switchable gratings. Perhaps the most exciting change will be benefitting from BNS’ incomparable research and development team. “I am pleased that we are integrating the best of both companies with this agreement. Combining great product offerings and technical expertise Meadowlark is poised to make significant advancements across a variety of markets,” offered Steve Serati, Chief Technology Officer, Boulder Nonlinear Systems. Look for Meadowlark’s new offerings at trade shows, on meadowlark.com, and on social media throughout 2023. For more information on the acquisition, contact Kelly Gregorak at 303.433.8333. About Meadowlark Meadowlark Optics, located in Frederick, CO, manufactures polarization solution components, including liquid crystal shutters, rotators, and spatial light modulators for wavelengths ranging from the UV to the MWIR. OEM customers and researchers worldwide use the products in various applications, including microscopy, aerospace, defense, telecommunications, automotive, semiconductor manufacturing, medical devices, and more. Our 20,000 SF headquarters boasts the latest in clean rooms, optical fabrication, and metrology facilities to ensure precision and top quality. (Added: Tue May 02 2023 Hits: 56 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... [>>]


Links SQL By: Gossamer Threads Inc.